# Knight Therapeutics Inc. (KHTRF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KHTRF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 148.82M | $ 13.20M | $ 37.22M | $ 69.96M | $ 789.31M |
| 2025 | $ 450.15M | $ -5.59M | $ 39.03M | $ 77.85M | $ 766.65M |
| 2024 | $ 378.34M | $ 4.41M | $ 4.51M | $ 49.46M | $ 795.11M |
| 2023 | $ 340.55M | $ -17.47M | $ 26.33M | $ 69.09M | $ 746.87M |
| 2022 | $ 314.95M | $ -32.07M | $ 15.73M | $ 77.70M | $ 825.86M |
| 2021 | $ 277.73M | $ 17.88M | $ -204.82M | $ 40.96M | $ 842.02M |
| 2020 | $ 238.52M | $ 50.29M | $ -43.87M | $ 56.19M | $ 886.24M |
| 2019 | $ 57.15M | $ 17.48M | $ 1.98M | $ 62.18M | $ 810.73M |
| 2018 | $ 15.39M | $ 29.65M | $ -11.84M | $ 0 | $ 1.03B |
| 2017 | $ 10.84M | $ 21.65M | $ 16.82M | $ 0 | $ 991.21M |
| 2016 | $ 7.60M | $ 23.74M | $ 5.49M | $ 0 | $ 979.72M |
| 2015 | $ 1.35M | $ 44.36M | $ 10.26M | $ 0 | $ 642.06M |
| 2014 | $ 482.0K | $ 166.05M | $ 1.12M | $ 0 | $ 478.99M |
| 2013 | $ 2.09M | $ 536.0K | $ 1.98M | $ 0 | $ 139.2K |
| 2012 | $ 627.7K | $ 77.2K | $ 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.09 |
| Liabilities / Eq | 0.38 |
| Current Ratio | 2.32 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 5.71 |

## Other views

- [Metrics](https://sponda.capital/en/KHTRF.md)
- [Charts](https://sponda.capital/en/KHTRF/charts.md)
- [Compare](https://sponda.capital/en/KHTRF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.